| Primary |
| Tonsillitis |
60.0% |
| Ear Infection |
10.0% |
| Pharyngitis |
10.0% |
| Product Used For Unknown Indication |
10.0% |
| Pyrexia |
10.0% |
|
| Arthralgia |
12.5% |
| Blindness Transient |
12.5% |
| Erythema Nodosum |
12.5% |
| Face Oedema |
12.5% |
| Henoch-schonlein Purpura |
12.5% |
| Myalgia |
12.5% |
| Rash |
12.5% |
| Stevens-johnson Syndrome |
12.5% |
|
| Secondary |
| Product Used For Unknown Indication |
39.9% |
| Urinary Tract Infection |
7.0% |
| Hiv Infection |
5.8% |
| Pyrexia |
5.8% |
| Self Injurious Behaviour |
4.0% |
| Abdominal Pain |
3.7% |
| Tuberculosis |
3.7% |
| Bipolar Disorder |
3.0% |
| Evidence Based Treatment |
3.0% |
| General Physical Health Deterioration |
3.0% |
| Rash Generalised |
3.0% |
| Rash Pruritic |
3.0% |
| Intentional Self-injury |
2.4% |
| Liver Abscess |
2.1% |
| Prophylaxis |
2.1% |
| Nausea |
1.8% |
| Tonsillitis |
1.8% |
| Arthralgia |
1.5% |
| Asthenia |
1.5% |
| Myalgia |
1.5% |
|
| Urticaria |
14.0% |
| Relapsing Fever |
11.6% |
| Self Injurious Behaviour |
9.3% |
| Vomiting |
7.0% |
| Acute Generalised Exanthematous Pustulosis |
4.7% |
| Drug Hypersensitivity |
4.7% |
| Erythema Nodosum |
4.7% |
| Pruritus |
4.7% |
| Pseudomembranous Colitis |
4.7% |
| Pyrexia |
4.7% |
| Rash Maculo-papular |
4.7% |
| Staphylococcal Infection |
4.7% |
| Toxic Skin Eruption |
4.7% |
| Abdominal Wall Haematoma |
2.3% |
| Acute Myocardial Infarction |
2.3% |
| Acute Respiratory Failure |
2.3% |
| Agranulocytosis |
2.3% |
| Cerebellar Syndrome |
2.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.3% |
| Dysarthria |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.6% |
| Rhabdomyosarcoma |
5.0% |
| Urinary Tract Infection |
5.0% |
| Uveitis |
4.9% |
| Sarcoma |
4.2% |
| Arthralgia |
4.1% |
| Hypertension |
4.1% |
| Bronchitis |
3.3% |
| Depression |
3.3% |
| Drug Use For Unknown Indication |
3.3% |
| Neuroblastoma |
3.3% |
| Diabetes Mellitus |
3.1% |
| Multiple Myeloma |
3.0% |
| Blood Pressure |
2.9% |
| Prophylaxis |
2.9% |
| Headache |
2.3% |
| Pain |
2.3% |
| Sarcoma Metastatic |
2.3% |
| Anxiety |
2.0% |
| Diffuse Large B-cell Lymphoma |
2.0% |
|
| Gastroenteritis Viral |
11.4% |
| Septic Shock |
11.4% |
| Dyspnoea |
7.1% |
| Renal Failure Acute |
7.1% |
| Neutropenia |
5.7% |
| Tendon Pain |
5.7% |
| Urinary Tract Infection |
5.7% |
| Haemoglobin Decreased |
4.3% |
| Mucosal Inflammation |
4.3% |
| Pancytopenia |
4.3% |
| Thrombocytopenia |
4.3% |
| Varicella |
4.3% |
| Vomiting |
4.3% |
| Abortion Spontaneous |
2.9% |
| Basal Cell Carcinoma |
2.9% |
| Bronchopneumonia |
2.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.9% |
| Drug-induced Liver Injury |
2.9% |
| Eosinophilia |
2.9% |
| Erythema |
2.9% |
|
| Interacting |
| Atrial Fibrillation |
27.3% |
| Bronchitis |
18.2% |
| Epilepsy |
18.2% |
| Respiratory Tract Infection |
18.2% |
| Ill-defined Disorder |
9.1% |
| Urinary Tract Infection |
9.1% |
|
| Status Epilepticus |
50.0% |
| Drug Interaction |
25.0% |
| Nausea |
25.0% |
|
